Newsroom

Home/Newsroom/

LRG Webcast Series: GIST, TKI Treatment & Effects on Memory

This discussion reviewed CRCI in general, and how a person who is being treated for GIST could be affected. We also talked about strategies that can help ameliorate CRCI, new research on CRCI and GIST. we also gave advice on how cancer survivors can best cope with and care for themselves during this unusual global health event.

By |2020-05-16T10:45:08-04:00May 15th, 2020|Webcast|

Blueprint Medicines Does Not Receive Approval from FDA for Avapritinib for Treatment of 4L GIST

Blueprint Medicines Does Not Receive Approval from FDA for Avapritinib for Treatment of 4L GIST.

By |2020-05-15T10:10:47-04:00May 15th, 2020|Ayvakit, Clinical Trials, News|

Life Raft Group Contributes Abstracts for ASCO

Although the ASCO (American Society for Clinical Oncology) will be a virtual meeting this year, The Life Raft Group continues to be at the forefront in collaborating in efforts to improve treatment for cancer patients. This year, two important abstracts will be presented online that illustrate these efforts.

By |2020-05-19T11:25:17-04:00May 13th, 2020|News, Research|

COVID-19 – Resources GIST Patients Need

COVID-19 - Resources GIST Patients Need - Please know that the Life Raft Group is here to support you during this Coronavirus crisis. We will continue our daily services during this time and we will be distributing information and messages of hope through all our communication channels.

By |2020-05-19T11:27:31-04:00May 13th, 2020|News, Patient Support|

Salud con Datos Produces Unique Analysis of Chilean & Mexican Patient Registries

This study is the result of a collaborative effort between Chile and Mexico, called Salud con Datos that sought to determine GIST prevalence, patients’ clinical characteristics and survival rates. Our report is the largest of its kind in Latin America.

By |2020-05-07T11:33:29-04:00May 7th, 2020|Global, News, Patient Registry|

Dr. Gina D’Amato, GIST Specialist, Talks Advances in Sarcoma

In a recent post by Oncology Nursing News, Dr. Gina D'Amato, associate professor and assistant director of Clinical Research at Sylvester Comprehensive Cancer Center, University of Miami Health System, discusses the evolution of treatment in sarcoma, the use of NGS, and predictive and prognostic biomarkers under investigation in the space.

By |2020-05-01T11:40:35-04:00May 1st, 2020|Mutational Testing, News, Research|

Blueprint Medicines Presents Cost of Testing Poster

Blueprint Medicines presented a poster titled “The Cost Impact of Increased Molecular Testing Rates for the Treatment of Patients with Gastrointestinal Stromal Tumors” at the annual meeting of the AMCP.

By |2020-04-30T14:50:52-04:00April 30th, 2020|Mutational Testing, News, Patient Support|

Science Forum Convened to Better Understand the State of GIST Research

As research regarding GIST and other relevant topics is extensive and dynamic, consensus among the Real World Evidence Team was that it would be a good idea to convene a group tasked with monitoring and assessing this research. Recently the LRG held its inaugural virtual meeting of the newly formed LRG Science Forum.

By |2020-04-28T15:55:34-04:00April 28th, 2020|News, Newsletter, Research|